C4 Therapeutics, Inc.CCCCNASDAQ
Loading
EBITDA as a percentage of revenue
Latest
-286.29%
Near historical average
Percentile
P43
Within normal range
Streak
2 yr
Consecutive growthContracting
Average
-267.95%
Historical baseline
| Period | Value | YoY Change |
|---|---|---|
| 2025 | -286.29% | +1.4% |
| 2024 | -290.49% | +50.6% |
| 2023 | -588.28% | -47.2% |
| 2022 | -399.68% | -128.0% |
| 2021 | -175.29% | +1.1% |
| 2020 | -177.23% | -19.5% |
| 2019 | -148.26% | -89.9% |
| 2018 | -78.06% | - |